Philips Respironics, Inc. 2026-04-01 Health critical FDA
Health · FDA · Recall #FDA-Z-1616-2026
Philips Respironics Trilogy EV300, Software Version 1.05.15.00. Continuous home-use… Recall
Issued April 1, 2026 · Philips Respironics, Inc.
In April 2026, Philips Respironics, Inc. recalled the Philips Respironics Trilogy EV300, Software Version 1.05.15.00. Continuous home-use…, a critical health recall reported by the FDA. Affected owners are eligible for a voluntary. Here is what the hazard is and exactly what to do about it.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Using non-pneumatic nebulizers with Trilogy Evo Platform ventilators may result in a discrepancy between the set tidal volume and the tidal volume received by the patient.
What you should do
- 1 Stop using Philips Respironics Trilogy EV300, Software Version 1.05.15.00. Continuous home-use… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Philips Respironics, Inc. to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Philips Respironics, Inc.
- Category
- Health
- Recall date
- April 1, 2026
- Units affected
- Not reported
- Sold at
- Worldwide distribution: US (Nationwide) and OUS (Foreign) to countries of: Argentina, Austria, Australia, Bosnia and Herzegovina, Bangladesh
- Recall number
- FDA-Z-1616-2026
- Made in
- United States
- Issuing agency
- FDA
In context
- Philips Respironics, Inc. has 7 recalls in our database, including 7 rated Critical.
- We're tracking 3,576 Health recalls in our database.
- This is the 356th Health recall we've logged in 2026.